Iradimed (IRMD) EPS (Basic) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.72% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 58.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 5.98% |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 19.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.43% |
| Dec 31, 2025 | 20.70% |
| Sep 30, 2025 | 17.68% |
| Jun 30, 2025 | 20.06% |
| Mar 31, 2025 | 22.76% |
| Dec 31, 2024 | 8.61% |
| Sep 30, 2024 | 23.96% |
| Jun 30, 2024 | 48.12% |
| Mar 31, 2024 | 44.22% |
| Dec 31, 2023 | 93.10% |
| Sep 30, 2023 | 64.41% |
| Jun 30, 2023 | 57.96% |
| Mar 31, 2023 | 21.64% |
| Dec 31, 2022 | 1.18% |
| Sep 30, 2022 | 7.06% |
| Jun 30, 2022 | 11.02% |
| Mar 31, 2022 | 5.57% |
| Dec 31, 2021 | 25.99% |
| Sep 30, 2021 | -1.54% |
| Jun 30, 2021 | -2.63% |
| Mar 31, 2021 | 11.20% |
| Dec 31, 2020 | 35.72% |
| Sep 30, 2020 | 65.10% |
| Jun 30, 2020 | -97.18% |
| Mar 31, 2020 | 111.79% |
| Dec 31, 2019 | 36.54% |
| Sep 30, 2019 | 13.62% |
| Jun 30, 2019 | -3.28% |
| Mar 31, 2019 | -6.80% |
| Dec 31, 2018 | -8.67% |
| Sep 30, 2018 | 8.97% |
| Jun 30, 2018 | -6.69% |
| Mar 31, 2018 | -17.02% |
| Dec 31, 2017 | 25.99% |
| Sep 30, 2017 | 0.00% |
| Jun 30, 2017 | -41.52% |
| Mar 31, 2017 | -31.73% |
| Dec 31, 2016 | 16.26% |
| Sep 30, 2016 | 55.36% |
| Jun 30, 2016 | 37.95% |